Credo Diagnostics nabs CE mark for VitaPCR™ Flu A/B and VitaPCR™ RSV external control sets
Taiwan, January 10, 2022 –Credo Diagnostics Biomedical […]
Taiwan, January 10, 2022 –Credo Diagnostics Biomedical […]
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.